Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05003141
Title PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
Age Groups: senior | adult
Covered Countries USA | AUS

No variant requirements are available.